Esperion Therapeutics, Inc.
ESPR
Revenue
87.31M
▲4.92M▲5.98%
3 Months ChangeAssets
364.02M
▲16.94M▲4.88%
3 Months ChangeLiabilities
815.38M
▲34.79M▲4.46%
3 Months ChangeFree Cash Flow
-22.63M
▼-76.38M▼-142.09%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-03
Form 8-K
ID: 0001628280-26-013552
2026-01-12
Form 8-K
ID: 0001628280-26-001764
2025-11-06
Form 10-Q
ID: 0001628280-25-050165
2025-11-06
Form 8-K
ID: 0001628280-25-049866
2025-11-04
Form 8-K
ID: 0001628280-25-048557
2025-10-08
Form 8-K
ID: 0001104659-25-097992
2025-10-07
Form 8-K
ID: 0001104659-25-097506
2025-08-13
Form 10-Q
ID: 0001628280-25-040139
2025-08-05
Form 8-K
ID: 0001628280-25-037601
2025-07-01
Form 8-K
ID: 0001628280-25-033612